NCT06270576View on ClinicalTrials.gov

Nasal Inflammation Following Endotoxin Challenge in Patients With Asthma

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 30, 2024

Primary Completion Date

April 30, 2028

Study Completion Date

June 30, 2028

Conditions
Asthma; EosinophilicAsthma
Interventions
DRUG

Lipopolysaccharides

LPS aka endotoxin is a component of bacterial cell walls and is ubiquitous in the environment. It is found in pet dander, house dust and environmental dusts and has been heavily studied in asthma.

Trial Locations (1)

80206

National Jewish Health, Denver

All Listed Sponsors
lead

National Jewish Health

OTHER